Contact US

We’re making exciting progress advancing our therapeutic and our biomarker test for ALS, and we’re now actively expanding our novel discoveries and AI-based biomarker platform to other neurodegenerative diseases including Alzheimer’s and Parkinson’s.

For investment and business development opportunities, contact: